Prudential Financial Inc Invitae Corp Transaction History

Prudential Financial Inc

$70.5 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.42 - $0.72 $3,780 - $6,480	-9,000 Reduced 29.02%	22,010 $13,000
Q3 2023 Nov 13, 2023	BUY	$0.6 - $1.53 $4,560 - $11,628	7,600 Added 32.46%	31,010 $18,000
Q2 2023 Aug 11, 2023	BUY	$1.05 - $1.63 $6,720 - $10,432	6,400 Added 37.62%	23,410 $26,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $820 - $1,732	-480 Reduced 2.74%	17,010 $0
Q3 2022 Nov 04, 2022	BUY	$1.9 - $8.63 $209 - $949	110 Added 0.63%	17,490 $45,000

Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $1,297 - $5,487	609 Added 3.63%	17,380 $92,000
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $39,124 - $97,125	-6,230 Reduced 27.09%	16,771 $134,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $70,016 - $136,555	4,763 Added 26.12%	23,001 $612,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $4,084 - $5,644	168 Added 0.93%	18,238 $575,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $580,763 - $899,304	-22,260 Reduced 55.19%	18,070 $610,000
Q1 2021 May 12, 2021	BUY	$33.06 - $56.93 $972,757 - $1.68 Million	29,424 Added 269.8%	40,330 $1.54 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $390,352 - $573,196	9,986 Added 1085.43%	10,906 $456,000
Q3 2020 Aug 05, 2021	SELL	$28.43 - $44.67 $328,650 - $516,385	-11,560 Reduced 92.63%	920 $40,000
Q3 2020 Nov 16, 2020	SELL	$28.43 - $44.67 $2.04 Million - $3.2 Million	-71,672 Reduced 85.17%	12,480 $541,000
Q2 2020 Aug 12, 2020	BUY	$11.71 - $30.29 $824,641 - $2.13 Million	70,422 Added 512.91%	84,152 $2.55 Million
Q3 2019 Nov 13, 2019	BUY	$18.85 - $27.5 $95,758 - $139,700	5,080 Added 58.73%	13,730 $264,000
Q2 2019 Aug 08, 2019	BUY	$17.37 - $26.27 $150,250 - $227,235	8,650 New	8,650 $0

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account